Catalyst Wire Dossier Catalyst Wire Dossier

RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)

· MedTrace Pharma A/S
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW), covering 2026-07-10 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Update: RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) [Phase 3]

See pricing